
healthcare & pharmaceutical
US FDA Grants Infectious Disease Product
Venus Remedies Limited specializing in critical care injectables, announced that its investigational product VRP-034 has been granted Qualified Infectious Disease Product (QIDP) designation by the United States Food and Drug Administration (US FDA) for the treatment of bloodstream infections caused by polymyxin B (PMB)-susceptible strains in adults. Developed by